Rutgers has granted Tonix Pharmaceutical exclusive worldwide rights to develop and commercialize a novel class of compounds created by university researchers with the potential to transform pain management and address the opioid epidemic.
Research in the News
Rutgers Advances Non-Opioid Solutions for Chronic Pain
- Click for News Details
- Faculty Referenced: Welsh, William J